0001415889-17-001686.txt : 20171023 0001415889-17-001686.hdr.sgml : 20171023 20171023174734 ACCESSION NUMBER: 0001415889-17-001686 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171019 FILED AS OF DATE: 20171023 DATE AS OF CHANGE: 20171023 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Riddell Alastair CENTRAL INDEX KEY: 0001681349 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37853 FILM NUMBER: 171149678 MAIL ADDRESS: STREET 1: C/OAZURRX BIOPHARMA,INC.760 PARKSIDE AVE STREET 2: DOWNSTATE BIOTECHNOLOGY INCUBATOR,STE217 CITY: BROOKLY STATE: NY ZIP: 11226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AzurRx BioPharma, Inc. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 BUSINESS PHONE: 646-699-7855 MAIL ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 4 1 form4-10232017_021023.xml X0306 4 2017-10-19 0001604191 AzurRx BioPharma, Inc. AZRX 0001681349 Riddell Alastair SUITE 304 BROOKLYN NY 11226 true false false false Common Stock 2017-10-19 4 A 0 22500 A 32500 D Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarters ending March 31, 2017, June 30, 2017, and September 30, 2017. /s/ Alastair Riddell 2017-10-23